To ascertain whether GSK-3β may play different roles in various cancer types, we examined the effects of WT-GSK-3β, KD-GSK-3β, and pLXSN on the therapeutic sensitivity of MCF-7 breast cancer cells. This evidence concerns the gene GSK3B and cancer.